Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balances at Dec. 31, 2019 $ 33,150   $ 1 $ 150,280 $ 26 $ (117,157)  
Balance (in shares) at Dec. 31, 2019     551,000        
Common stock issued (in shares)     5,000        
Stock-based compensation 1,047     1,047      
Other comprehensive Income (loss) (22)       (22)    
Net loss (7,701)         (7,701)  
Balances at Mar. 31, 2020 26,474   $ 1 151,327 4 (124,858)  
Balance (in shares) at Mar. 31, 2020     556,000        
Balances at Dec. 31, 2019 33,150   $ 1 150,280 26 (117,157)  
Balance (in shares) at Dec. 31, 2019     551,000        
Other comprehensive Income (loss) (26)            
Net loss (17,822)            
Balances at Jun. 30, 2020 26,984   $ 4 161,959   (134,979)  
Balance (in shares) at Jun. 30, 2020     1,527,000        
Balances at Mar. 31, 2020 26,474   $ 1 151,327 4 (124,858)  
Balance (in shares) at Mar. 31, 2020     556,000        
Common stock issued, net 5,284   $ 2 5,282      
Common stock issued (in shares)     889,000        
Warrants issued, net 3,464     3,464      
Exercise of warrants 827   $ 1 826      
Exercise of warrants (in shares)     73,000        
Common stock issued pursuant to the vesting of restricted stock units and ESPP 27     27      
Common stock issued pursuant to the vesting of restricted stock units and ESPP (in shares)     9,000        
Stock-based compensation 1,033     1,033      
Other comprehensive Income (loss) (4)       $ (4)    
Net loss (10,121)         (10,121)  
Balances at Jun. 30, 2020 26,984   $ 4 161,959   (134,979)  
Balance (in shares) at Jun. 30, 2020     1,527,000        
Balances at Dec. 31, 2020 21,147   $ 7 174,342   (153,202)  
Balance (in shares) at Dec. 31, 2020     3,189,000        
Common stock issued, net 65     65      
Common stock issued (in shares)     35        
Accounting Standards Update [Extensible List]   us-gaap:AccountingStandardsUpdate201807Member         us-gaap:AccountingStandardsUpdate201807Member
Stock-based compensation 1,169     1,169      
Stock-based compensation (In shares)     35        
Net loss (7,236)         (7,236)  
Balances at Mar. 31, 2021 15,145   $ 7 175,576   (160,438)  
Balance (in shares) at Mar. 31, 2021     3,259,000        
Balances at Dec. 31, 2020 21,147   $ 7 174,342   (153,202)  
Balance (in shares) at Dec. 31, 2020     3,189,000        
Net loss (12,485)            
Balances at Jun. 30, 2021 21,263   $ 7 186,943   (165,687)  
Balance (in shares) at Jun. 30, 2021     5,903,000        
Balances at Mar. 31, 2021 15,145   $ 7 175,576   (160,438)  
Balance (in shares) at Mar. 31, 2021     3,259,000        
Common stock issued, net 10,645     10,645      
Common stock issued (in shares)     2,582        
Common stock issued pursuant to the vesting of restricted stock units and ESPP 26     26      
Common stock issued pursuant to the vesting of restricted stock units and ESPP (in shares)     6        
Stock-based compensation 696     696      
Stock-based compensation (In shares)     56        
Net loss (5,249)         (5,249)  
Balances at Jun. 30, 2021 $ 21,263   $ 7 $ 186,943   $ (165,687)  
Balance (in shares) at Jun. 30, 2021     5,903,000